Atea Pharmaceuticals, Inc.
Recent Filings
All 294 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 4 | 4 | Mar 13, 2026 |
| 10-K | 10-K | Mar 5, 2026 |
| 8-K | 8-K | Mar 5, 2026 |
| SCHEDULE 13G | — | Feb 9, 2026 |
| 4 | 4 | Feb 3, 2026 |
| 4 | 4 | Feb 3, 2026 |
| 4 | 4 | Feb 3, 2026 |
| 4 | 4 | Feb 3, 2026 |
| 4 | 4 | Feb 3, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Hammond Janet MJ | Chief Development Officer | Award / Grant | 11,250 | 95,522 | Jan 31, 2025 |
| BERGER FRANKLIN M | — | Purchase | 10,000 @ $3.36 | 476,897 | Jan 15, 2025 |
| BERGER FRANKLIN M | — | Purchase | 10,000 @ $3.36 | 476,897 | Jan 15, 2025 |
| BERGER FRANKLIN M | — | Sale | 359,606 @ $2.85 | 451,897 | Dec 10, 2024 |
| Sommadossi Jean-Pierre | President, CEO, and Chairman | Sale | 1,841 @ $4.00 | 5,866,025 | Sep 18, 2024 |
| Polsky Bruce | — | Sale | 17,544 @ $3.49 | 65,606 | Jun 20, 2024 |
| Sommadossi Jean-Pierre | President, CEO, and Chairman | Sale | 1,006 @ $4.00 | 5,923,994 | Jun 5, 2024 |
| Sommadossi Jean-Pierre | President, CEO, and Chairman | Sale | 56,910 @ $3.85 | 116,557 | Jan 31, 2024 |
| BERGER FRANKLIN M | — | Sale | 16,166 @ $5.16 | 778,353 | Nov 11, 2022 |
| Murphy Polly A. | — | Purchase | 12,000 @ $8.57 | 23,295 | Dec 20, 2021 |